DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease
about
Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway.An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases
P2860
DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
DAP12 and CD11b contribute to ...... e model of Parkinson's disease
@en
DAP12 and CD11b contribute to ...... model of Parkinson's disease.
@nl
type
label
DAP12 and CD11b contribute to ...... e model of Parkinson's disease
@en
DAP12 and CD11b contribute to ...... model of Parkinson's disease.
@nl
prefLabel
DAP12 and CD11b contribute to ...... e model of Parkinson's disease
@en
DAP12 and CD11b contribute to ...... model of Parkinson's disease.
@nl
P2093
P2860
P50
P921
P356
P1476
DAP12 and CD11b contribute to ...... e model of Parkinson's disease
@en
P2093
Daniel Alvarez-Fischer
Etienne C Hirsch
Yann Monnet
P2860
P2888
P356
10.1186/1742-2094-10-82
P577
2013-07-11T00:00:00Z
P5875
P6179
1053198259